The development of sensitive assays for thyrotropin (TSH) has led to t
he discovery that many older patients have abnormal TSH levels without
other alterations in serum thyroid hormone levels, conditions termed
subclinical hypothyroidism (isolated elevation of TSH levels);Ind subc
linical hyperthyroidism (isolated suppression of TSH levels). Subclini
cal hypothyroidism occurs in 5% to 10% of elderly subjects, and is esp
ecially prevalent in elderly women. Subclinical hyperthyroidism is les
s common, affecting less than 2% of the elderly population. The causes
of subclinical thyroid disease in the elderly are similar to those of
thyroid disease in the general population, although medications and i
odine-containing compounds may Flay an increased role. Potential risks
of subclinical hypothyroidism in the elderly include progression to o
vert hypothyroidism, cardiovascular effects, hyperlipidemia, and neuro
logical and neuropsychiatric effects. Potential risks of subclinical h
yperthyroidism in the elderly include progression to overt hyperthyroi
dism, cardiovascular effects (especially atrial fibrillation), and ost
eoporosis. Decisions to treat elderly subjects with subclinical thyroi
d disease should be based on a careful assessment of these risks in th
e individual patient.